The research interests of Timothy D. Lyon, M.D., are centered on improving the lives of patients with bladder cancer. He is engaged in health services research focused on improving access to, quality of and delivery of bladder cancer care. Additionally, Dr. Lyon studies the safety and efficacy of novel urothelial cancer treatments in multiple clinical trials.
- Care delivery for bladder cancer. Dr. Lyon studies patterns of health care delivery for patients with bladder cancer, with a particular focus on developing and optimizing new strategies to improve the patient experience of care.
- Disparities in access to bladder cancer care. Much of Dr. Lyon's work is focused on identifying disparities in access to and recovery from bladder cancer surgery and using these insights to design interventions to help bridge gaps in care.
- Clinical trials of new therapies for urothelial carcinoma. Dr. Lyon contributes to numerous clinical trials investigating new therapies to treat cancer of the cells that line the inside of the bladder and upper urinary tract (urothelial carcinoma).
Significance to patient care
Bladder cancer is the one of the most common types of cancer, usually occurring in older patients with coexisting medical problems. This confluence of factors increases the complexity of caring for patients with bladder cancer. Accordingly, there are wide variations in the quality of care delivered for bladder cancer across the United States and worldwide.
Dr. Lyon and his colleagues focus on identifying patient- and provider-level features associated with the delivery of high-quality bladder cancer care. They use these insights to create and disseminate strategies to improve the delivery of care for patients with bladder cancer.